Effects of entinostat onresistance to cetuximab and EGFR TKIs in non-small cell lung cancer

被引：0
|
作者：
Witta, Samir E.
Chan, Dan
Girard, Luc
Zheng, Di
Franekova, Veronica
Peyton, Michael
Zhang, Zhi-Yong
Kline, Zoe
Minna, John D.
Bunn, Paul A.
Hirsch, Fred R.
机构：
[1] Mt Blue Canc Care Ctr, Golden, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18077
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COMPARISON OF EGFR-TKIS AND PEMETREXED FOR KOREAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, J. H.
    Ryu, Y. J.
    Chun, E. M.
    Chang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S90 - S90
  • [22] Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond
    Li, Xin
    Lin, Yongping
    Lin, Song
    Huang, Jiayi
    Ruan, Zhongbao
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] The evolving role of cetuximab in non-small cell lung cancer
    Lilenbaum, Rogerio C.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4432S - 4435S
  • [24] Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC) cell lines
    Mukohara, T
    Engelman, J
    Lindeman, N
    Pearlberg, J
    Cantley, L
    Johnson, B
    Jänne, P
    LUNG CANCER, 2005, 49 : S7 - S7
  • [25] EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis
    Thang Thanh Phan
    Vinh Thanh Tran
    Bich-Thu Tran
    Toan Trong Ho
    Suong Phuoc Pho
    Anh Tuan Le
    Vu Thuong Le
    Hang Thuy Nguyen
    Son Truong Nguyen
    CANCER REPORTS, 2022, 5 (08)
  • [26] Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
    Mari Tone
    Kota Iwahori
    Takayuki Shiroyama
    Shinji Futami
    Yujiro Naito
    Kiyoharu Fukushima
    Kotaro Miyake
    Shohei Koyama
    Haruhiko Hirata
    Izumi Nagatomo
    Hisashi Wada
    Yoshito Takeda
    Atsushi Kumanogoh
    Scientific Reports, 13
  • [27] Entinostat (SNDX-275) for the treatment of non-small cell lung cancer
    Ruiz, Rossana
    Raez, Luis E.
    Rolfo, Christian
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (08) : 1101 - 1109
  • [28] A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
    Cui, Ran
    Wei, Chun
    Li, Xianyi
    Jiang, Ou
    MEDICINE, 2022, 101 (47) : E31894
  • [29] FIRST GENERATION EGFR- TKIS COMPARISON IN NON-SMALL CELL LUNG CANCER PATIENTS HARBOURING SENSITIVE EGFR MUTATIONS
    Chang, Chia Hao
    Ko, Jen-Chung
    Yu, Chong-Jen
    RESPIROLOGY, 2018, 23 : 284 - 284
  • [30] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
12345